Table 1.
Summary of tested drugs displaying antiaggregation activity toward bovine γ-crystallin-rich proteins exposed to oxidant stress for 24 h and/or thermal stress at 72 °C for 20 min
| Compound name | MW (g) | Usage | Properties | Antiaggregation activity | Provenience, appearance |
|---|---|---|---|---|---|
Bixin (drug B)
|
394.5 | Food color | Antineoplastic | Medium heat shock inhibitor | Orange colored solid |
Closantel (drug C)![]() Two enantiomers C(R) and C(S) |
663.1 | Clinical drug | Antihelminthic | Medium strong dual inhibitor | Synthetic, clear solid, colorless |
Chaulmoogric acid (drug M)
|
280.4 | Experimental drug | Antibacterial, antileprotic | Dual heat shock inhibitor + antioxidant | Natural product, colorless, oily |
Gambogic acid (drug G)
|
628.7 | Experimental drug | Anti-inflammatory, anticancer, multiple actions | Strong heat shock inhibitor | Natural product, yellow solid |
| Dihydrogambogic (drug D) Acid (reduced G) |
630.8 | Experimental drug | Undetermined activity | Strong heat shock inhibitor | Modified natural product, solid |
Hexachlorophene (drug X)
|
406.9 | Clinical drug | Topical antimicrobial | Medium heat shock inhibitor | Synthetic, solid, colorless |
